Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and ...

The trial is conducted at the Mays Cancer Center, part of the University of Texas at San Antonio’s Health Science Center.

Scientists at The Wistar Institute have identified a previously overlooked mediator in the body's response to life-threatening infections: hippuric acid, a metabolite produced when gut bacteria break ...

Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed ...

Heart disease remains the leading cause of death for women. Despite advancements in awareness and research, gaps remain in ...

Professor Lisa Volpatti developed a targeted approach that directs anti-inflammatory proteins to diseased arteries, reducing ...

Dr. Shune continues the case discussion by describing disease progression following second-line therapy and outlining her approach to third-line treatment selection in cGVHD. After initiating systemic ...

A team from UNIGE reveals how the 'hijacking' of neutrophils, a type of immune cell, promotes cancer growth and could provide insights into disease progression.

Giloy, also known as Guduchi or Amrita in Ayurveda, is more than just a medicinal herb, it is considered the "root of immortality" in ancient Indian texts. For centuries, it has beenused to strengthen ...

Scientists at The Wistar Institute have identified a previously overlooked mediator in the body's response to ...

Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...